Get Live Data

Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Oncimmune Share Price
  4. Oncimmune Share News
  5. Oncimmune inks distribution deal for lung cancer test in Portugal

Pin to quick picksOncimmune Share News (ONC)

Oncimmune Information

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.35
Bid: 14.00
Ask: 14.90
Change: 0.00 (0.00%)
Spread: 0.90 (6.429%)
Open: 14.35
High: 0.00
Low: 0.00
Prev. Close: 14.35
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oncimmune inks distribution deal for lung cancer test in Portugal

Fri, 05th Apr 2019 15:10

(Sharecast News) - Personalised immunodiagnostics developer Oncimmune Holdings has signed an exclusive agreement for the distribution of its 'EarlyCDT-Lung' test kit in Portugal with Sabartech, its existing distributor in Spain, it announced on Friday.The AIM-traded company said the agreement included a minimum sales commitment of £0.7m over five years.It said that every year in Portugal, around 5,300 new cases were diagnosed and approximately 4,700 deaths occurred from lung cancer.Lung cancer remained the largest cause of cancer-related deaths in the country.Oncimmune said it had also extended Sabartech's agreement in Spain from three to five years, in light of the "excellent progress" made there - including the recently-secured agreement to sell EarlyCDT-Lung as a screening test for the early detection of lung cancer through the hospitals and clinics of the Quirónsalud group.The extension added a further £1.8m of minimum sales commitments over years four and five."Portugal and Spain are important European markets and Sabartech has made good progress so far including selling EarlyCDT-Lung for screening through Quirónsalud, the largest private hospital network in Spain," said Oncimmune chief executive officer Dr Adam Hill."Extending our relationship to include Portugal was a natural progression and marks another step in the commercialisation of EarlyCDT-Lung."
More News
25 Sep 2018 17:21

Oncimmune Says Lung Cancer Blood Test Outperforms Risk Calculator

LONDON (Alliance News) - Pharma company Oncimmune Holdings PLC on Tuesday said its lung cancer blood test, EarlyCDT-Lung, has proven to be more effective than a standard risk produced a positive a

Read more
24 Sep 2018 11:43

Oncimmune Appoints Adam Hill As New Boss, Founder Becomes Vice Chair

LONDON (Alliance News) - Oncimmune Holdings PLC said Monday it appointed Adam Hill as its new boss as current Chief Executive Officer Geoffrey Hamilton-Fairley prepares to move to vice-chairman -

Read more
27 Mar 2018 13:34

Oncimmune Gets Final GBP3 Million Genostics Investment After Deal (ALLISS)

LONDON (Alliance News) - Oncimmune Holdings PLC said Tuesday it has received the final GBP3.0 million tranche of a GBP10.0 million investment Co

Read more
7 Nov 2016 15:17

Revenue shrinks and costs rise at Oncimmune

(ShareCast News) - Early cancer detection company Oncimmune Holdings announced its full year results for the year to 31 May on Monday, including £12.2m raised by the issue of equity in the year. The firm also said £4.2m of convertible loan notes were converted. Revenues for the year were down signi

Read more
22 Sep 2016 09:01

Oncimmune Notes Asia Focus With Chief Commercial Officer Appointment

Read more
17 Aug 2016 07:23

Oncimmune Makes Acting CFO Millet Permanent Finance Chief

Read more
15 Jul 2016 16:17

Oncimmune secures CE mark for EarlyCDT-Lung

(ShareCast News) - Early cancer detection technology company Oncimmune Holdings announced on Friday that it has obtained the CE mark for the reagents used in its EarlyCDT-Lung product - an autoantibody blood test that can detect cancer up to four years earlier than other methods. The AIM-traded firm

Read more
15 Jul 2016 07:55

Oncimmune Secures European CE Mark For Product EarlyCDT-Lung

Read more
4 Jul 2016 07:26

Oncimmune Signs Research Agreements To Further Validate EarlyCDT Tests

Read more
6 Jun 2016 16:44

Oncimmunce Holdings CFO Robert Page dies

(ShareCast News) - Robert Page, director and CFO of Oncimmune Holdings, has died unexpectedly from natural causes. Oncimmune Holdings, an early cancer detection and technology company, said Page died on Friday morning. Page became CFO in 2005 after holding a series of finance roles at telecommunica

Read more
6 Jun 2016 13:21

Oncimmune Holdings Says Chief Financial Officer Robert Page Has Died

Read more
25 May 2016 07:58

Oncimmune Signs Three New Distribution Deals In US

Read more
18 May 2016 08:46

Oncimmune Starts Trading On AIM As Motorpoint Shares Stay Firm (ALLIPO)

Read more
123456789

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.